Unique ID issued by UMIN | UMIN000016463 |
---|---|
Receipt number | R000019122 |
Scientific Title | A randomized double-blind placebo-controlled trial for improving the intestinal environment in human |
Date of disclosure of the study information | 2015/02/06 |
Last modified on | 2017/01/30 18:28:14 |
A randomized double-blind placebo-controlled trial for improving the intestinal environment in human
A trial for improving the intestinal environment in human
A randomized double-blind placebo-controlled trial for improving the intestinal environment in human
A trial for improving the intestinal environment in human
Japan |
Healthy adults
Not applicable | Adult |
Others
NO
To investigate the effect of "Powder of the Fermented Extract from Plants EX" on the intestinal environment in human
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Intestinal bacterial flora
Bifidobacterium
Lactobacillales
Bacteroides
Prevotella
Clostridium cluster IV
Clostridium subcluster XIVa
Clostridium cluster XI
Clostridium cluster XVIII
Others
Subjective symptom
CAS-MT
The faecal form scale
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
2
Treatment
Food |
Duration: 4 weeks
Test material: "Powder of the Fermented Extract from Plants EX" capsules
Dose: One packet (1.2g)/day
Usage: ingestion of test material along with the water just after dinner
Duration: 4 weeks
Test material: Placebo
Dose: One packet (1.2g)/day
Usage: ingestion of test material along with the water just after dinner
20 | years-old | <= |
59 | years-old | >= |
Male and Female
a) Japanese healthy adults who are between 20 and 59 years old.
b) Persons whose stool frequencies are between 2 and 5 times per 7 days
a) Persons who have previous medical history of malignant tumor or heart failure or myocardial infarction
b) Patients being treated for at least one of following diseases atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension and other chronic disease
c) Persons who take medicines, herbal medicines, or supplement.
d) Persons who are allergic to medicines, or products related to the test material of this trial
e) Persons who habitually take foods that seem to be influential on intestinal environment, e.g., FOSHU, yogurt, and lactic fermenting beverage
f) Persons who smoke
g) Pregnant women, lactating women, or women who want to get pregnant during the trial period
h) Persons who have been enrolled in the other clinical trials within last 3 months before the agreement for the participation to this trial
i) Persons who are judged unsuitable to participate in this trial by physician
20
1st name | |
Middle name | |
Last name | Kazuo YAMAMOTO |
ORTHOMEDICO Inc.
R&D Department
25F M&D Tower, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo
03-3818-0610
kazu@orthomedico.jp
1st name | |
Middle name | |
Last name | Naoko SUZUKI |
ORTHOMEDICO Inc.
R&D Department
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.
03-3818-0610
nao@orthomedico.jp
ORTHOMEDICO Inc.
YAGUMO KOUSAN CO., LTD.
Profit organization
Seishin-kai Medical Association Inc, Takara Medical Clinic.
NO
2015 | Year | 02 | Month | 06 | Day |
Published
Completed
2015 | Year | 01 | Month | 14 | Day |
2015 | Year | 02 | Month | 09 | Day |
2015 | Year | 05 | Month | 31 | Day |
2015 | Year | 06 | Month | 19 | Day |
2015 | Year | 06 | Month | 22 | Day |
2015 | Year | 06 | Month | 26 | Day |
2015 | Year | 02 | Month | 06 | Day |
2017 | Year | 01 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019122